Free Trial

CME Group (CME) Earnings Date, Estimates & Call Transcripts

CME Group logo
$237.59 -0.94 (-0.39%)
(As of 01:44 PM ET)

CME Group Latest Earnings Summary

Actual EPS
(Oct. 23)
$2.68 Beat By $0.03
Consensus EPS
(Oct. 23)
$2.65

CME Group released Q3 2024 earnings on October 23, 2024, reporting an EPS of $2.68, which beat analysts' consensus estimates of $2.65 by $0.03. Quarterly revenue rose 18.4% year-over-year to $1.58 billion, below the consensus estimate of $1.59 billion. With a trailing EPS of $9.51 and a P/E Ratio of 24.93, CME Group's earnings are expected to grow 1.37% next year, from $10.22 to $10.36 per share.

Get CME Group Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on CME Group and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

CME Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CME Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

CME Group Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242$2.36$2.38$2.37
Q2 20242$2.27$2.38$2.33
Q3 20242$2.25$2.40$2.33
Q4 20242$2.16$2.47$2.32
FY 20248$9.04$9.63$9.34
Q1 20251$2.57$2.57$2.57
Q2 20251$2.50$2.50$2.50
Q3 20251$2.57$2.57$2.57
Q4 20251$2.56$2.56$2.56
FY 20254$10.20$10.20$10.20
Q1 20261$2.75$2.75$2.75
Q2 20261$2.71$2.71$2.71
Q3 20261$2.44$2.44$2.44

CME Group Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
10/23/2024Q3 2024$2.65$2.68+$0.03$2.86$1.59B$1.58B
7/24/2024Q2 2024$2.53$2.56+$0.03$2.70$1.53B$1.53B
4/24/2024Q1 2024$2.44$2.50+$0.06$2.65$1.48B$1.49B
2/14/2024Q4 2023$2.27$2.37+$0.10$2.50$1.43B$1.44B
10/25/2023Q3 2023$2.21$2.25+$0.04$2.44$1.34B$1.34B
7/26/2023Q2 2023$2.20$2.30+$0.10$2.46$1.34B$1.36B
4/26/2023Q1 2023$2.36$2.42+$0.06$2.41$1.42B$1.44B
2/8/2023Q4 2022$1.90$1.92+$0.02$2.09$1.21B$1.21B

CME Group Earnings - Frequently Asked Questions

CME Group (NASDAQ:CME) last announced its quarterly earning data on Wednesday, October 23, 2024. Learn more on CME's earnings history.

In the previous quarter, CME Group (NASDAQ:CME) reported $2.68 earnings per share (EPS) to beat the analysts' consensus estimate of $2.65 by $0.03. Learn more on analysts' earnings estimate vs. CME's actual earnings.

The conference call for CME Group's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for CME Group's latest earnings report can be read online.
Read Transcript

CME Group (NASDAQ:CME) has a recorded annual revenue of $6.04 billion.

CME Group (NASDAQ:CME) has a recorded net income of $3.23 billion. CME has generated $9.51 earnings per share over the last four quarters.

CME Group (NASDAQ:CME) has a trailing price-to-earnings ratio of 24.92 and a forward price-to-earnings ratio of 23.19. The price/earnings-to-growth ratio is 5.41.

CME Group's earnings are expected to grow from $10.22 per share to $10.36 per share in the next year, which is a 1.37% increase.

More Earnings Resources from MarketBeat



This page (NASDAQ:CME) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners